SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brucato A, Buyon JP, Horsfall AC, Lee LA, Reichlin M. Fourth international workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB system. Clin Exp Rheumatol 1999; 17: 1306.
  • 2
    Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 165866.
  • 3
    Ramsey-Goldman R, Hom D, Deng J-S, Ziegler GC, Kahl LE, Steen VD, et al. Anti–SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1986; 29: 126973.
  • 4
    Lockshin MD, Bonfa E, Elkon K, Druzin ML. Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum 1988; 31: 697701.
  • 5
    Julkunen H, Kurki P, Kaaja R, Heikkilä R, Immonen I, Chan EKL, et al. Isolated congenital heart block: long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993; 36: 158898.
  • 6
    Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D, et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children: comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti–SS-A/Ro and anti–SS-B/La antibodies. Arthritis Rheum 1993; 36: 126373.
  • 7
    Colombo G, Brucato A, Coluccio E, Compasso S, Luzzana C, Franceschini F, et al. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1999; 42: 175764.
  • 8
    Mazel JA, El Sherif N, Buyon J, Boutjdir M. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999; 99: 19148.
  • 9
    Boutjdir M, Chen L, Zhang ZH, Tseng CE, DiDonato F, Rashbaum W, et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 1997; 80: 35462.
  • 10
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 11
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 3407.
  • 12
    Clark G, Reichlin M, Tomasi TB Jr. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol 1969; 102: 11722.
  • 13
    Brucato A, Franceschini F, Gasparini M, de Juli E, Ferraro G, Quinzanini M, et al. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background. J Rheumatol 1995; 22: 53340.
  • 14
    Brucato A, Cimaz R, Catelli L, Meroni P. Anti-Ro-associated sinus bradycardia in newborns [letter]. Circulation 2000; 102: E889.
  • 15
    Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro–positive infants without congenital heart block. Arthritis Rheum 2000; 43: 104953.